Valion Bio, Inc.
VBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787740
No open-market purchases or sales by Valion Bio, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $205.6K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +4 vs. previous quarter
- 13
- 13F valueReported value at the end of Q2 2026
- $205.6K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding VBIO, Q2 2026
No superinvestor reported holding VBIO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Valion Bio, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 15 | 5 daysLate | Bolton SheryleDirector | PPurchase | +10.0K | $1.04 | +$10.4K | New position10.0K after | |
| Apr 2, 2026 (view filing) | Apr 1 | 1 day | Valauri Christina RizopoulosDirector | PPurchase | +19.0K | $0.95 | +$18.1K | New position19.0K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Valion Bio, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Murchinson Ltd. | 115,000 | $59.8K | 0.03% | +115,000 | New |
| Citadel Advisors LLC | 74,145 | $38.5K | 0.00% | +74,145 | New |
| Sanctuary Advisors, LLC | 61,205 | $31.8K | 0.00% | 00.0% | Unchanged |
| Marex Group plc | 54,287 | $28.2K | 0.00% | −4,976−8.4% | Reduced |
| Virtu Financial LLC | 39,225 | $20.0K | 0.00% | +39,225 | New |
| Geode Capital Management, LLC | 19,374 | $10.1K | 0.00% | −68,444−77.9% | Reduced |
| UBS Group AG | 11,094 | $5.77K | 0.00% | +8,728+368.9% | Added |
| Two Sigma Securities, LLC | 10,162 | $5.28K | 0.00% | +10,162 | New |
| HRT Financial LP | 11,462 | $5.00K | 0.00% | −30,957−73.0% | Reduced |
| Tower Research Capital LLC (TRC) | 2,095 | $1.09K | 0.00% | +1,511+258.7% | Added |
Holders of 5% or more of VBIO
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Valion Bio, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Murchinson Ltd. | 13G | 9.99%440.2K shares | New | Jul 17, 20261 filing | Jul 17, 2026 | SEC |
| 3i, LP | 13D/A | 9.90%3.33M shares | 0.00 ppfrom 9.90% | Feb 27, 20268 filings | Aug 27, 2026 | SEC |
| 3i, LP | 13G/A | 9.90%132.7K shares | 0.00 ppfrom 9.90% | Sep 2, 20263 filings | Sep 4, 2026 | SEC |